Welcome to FindMyBest CPA
Accounting & Financial Directory
Find local and nationwide accounting and financial businesses. We have located the best Accountants, CPAs, Accounting Firms, Tax Consultants, Tax Return Preparers, Bookkeepers and Financial Advisors in the US.
Business Directory
Pfizer Inc. Detail
Fortune 500 Company List

Pfizer Inc.

Stock Symbol: PFE

235 East 42nd Street

Pfizer Inc. Industry:
Major Drugs

Pfizer Inc. Description:
Pfizer Inc discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Our innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: health care, animal health and consumer health care. Our products are available in more than 150 countries.

Pfizer Inc. Financial Summary:
For the nine months ended 2 October 2005, Pfizer Inc.'s total revenues increased less than 1% to $37.71B. Net income from cont. ops. decreased 37% to $5.35B. Revenues reflect an increase in animal health pharmaceutical business segment. Net income was offset by the inclusion of merger-related in-process research and development charges of $1.39B, and an increase in restructuring charges and merger-related costs.

Pfizer Inc. Business Summary:
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals, as well as consumer healthcare products. The Company operates in three business segments: Human Health (previously named Pharmaceutical), Consumer Healthcare and Animal Health. It also operates several other businesses, including the manufacture of empty soft-gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals. Pfizer completed the acquisition of Esperion Therapeutics, Inc. on February 10, 2004. Esperion is a biopharmaceutical company focused on the development of high-density lipoprotein (HDL)-targeted (good cholesterol) therapies for the treatment of cardiovascular disease.

© Copyrights 2007, All Rights Reserved.
Home     AboutUs     CPA Directory     List Your Firm     Links     Privacy     Contact Us